Kristen Hege
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Kristen M.
Hege is a Professor at The University of California, San Francisco since 2008.
Former positions include Director at International Society for Biological Therapy of Cancer from 2016 to 2019, Independent Director at Mersana Therapeutics, Inc. from 2016 to 2026, Independent Non-Executive Director at Adaptimmune Therapeutics Plc from 2023 to 2025, Director at Baybio Institute from 2014 to 2016, Director at California Biomedical Innovation Alliance, Independent Director at Arcus Biosciences, Inc. from 2018 to 2019, Director at California Life Sciences Association from 2014 to 2016, Director at Society For Immunotherapy of Cancer from 2016 to 2019, Independent Director at Graphite Bio, Inc. from 2021 to 2024, Vice President-Translational Development at Celgene Corp.
from 2010 to 2019, Vice President-Clinical Research & Development at Cell Genesys, Inc. from 1996 to 2008, Chief Medical Officer at Cellerant Therapeutics, Inc. from 2009 to 2010, Chief Medical Officer at Theraclone Sciences, Inc. from 2009 to 2010, Chief Medical Officer at Aragon Pharmaceuticals, Inc. in 2010, and SVP-Clinical Development & Cell Therapy at Bristol Myers Squibb Co. from 2019 to 2023.
Education includes an undergraduate degree from Dartmouth College conferred in 1984 and a doctorate from The University of California, San Francisco conferred in 1989.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/04/2025 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/07/2008 |
| Sociétés | Poste | Fin |
|---|---|---|
| MERSANA THERAPEUTICS | Directeur/Membre du Conseil | 06/01/2026 |
| ADAPTIMMUNE THERAPEUTICS PLC | Directeur/Membre du Conseil | 14/11/2025 |
| LENZ THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/03/2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/03/2023 |
| ARCUS BIOSCIENCES, INC. | Directeur/Membre du Conseil | 20/11/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 17 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Health Technology |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Health Technology |
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as professional society of influential scientists, academicians, researchers, clinicians and government representatives | Commercial Services |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Baybio Institute | |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Health Technology |
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | Commercial Services |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national